carvedilol has been researched along with glycerol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barouhiel, E; Cabassi, A; Cantoni, AM; Cavazzini, S; Coghi, P; Fiaccadori, E; Govoni, P; Scandroglio, R; Speroni, E | 1 |
| Bandyopadhyay, S; Kapil, R; Katare, OO; Khurana, L; Singh, B | 1 |
3 other study(ies) available for carvedilol and glycerol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Glycerol; Heart Rate; Lipolysis; Losartan; Male; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Sterol Esterase; Sympathetic Nervous System; Triglycerides; Tyrosine 3-Monooxygenase | 2005 |
Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
Topics: Animals; Biological Availability; Caprylates; Carbazoles; Cardiovascular Agents; Carvedilol; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Emulsions; Ethylene Glycols; Excipients; Glycerides; Glycerol; Intestinal Absorption; Jejunum; Male; Microscopy, Electron, Transmission; Nanostructures; Oils; Particle Size; Perfusion; Propanolamines; Rats; Rats, Wistar; Solubility | 2011 |